ImmunoGen (IMGN) Reports a Q2 Loss, Updates FY08 Guidance
Tweet Send to a Friend
ImmunoGen, Inc. (Nasdaq: IMGN) reported a Q2 loss of $0.15, in-line with the analyst estimate of ($0.15) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


